Agios Pharmaceuticals (AGIO) P/E (2013 - 2026)
Agios Pharmaceuticals (AGIO) P/E from Jul 24, 2013 to Jul 21, 2026. The TTM Agios Pharmaceuticals (AGIO) P/E is -5.17. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Agios Pharmaceuticals (AGIO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.17 | +34.83% |
| 2025 | -3.84 | -237.85% |
| 2024 | 2.78 | -149.14% |
| 2023 | -5.66 | +33.82% |
| 2022 | -4.23 | -383.80% |
| 2021 | 1.49 | -116.29% |
| 2020 | -9.15 | +29.48% |
| 2019 | -7.07 | -8.51% |
| 2018 | -7.73 | -26.82% |
| 2017 | -10.56 | +17.79% |
| 2016 | -8.96 | -56.74% |
| 2015 | -20.71 | -81.27% |
| 2014 | -110.60 | +511.13% |
| 2013 | -18.10 | N/A |
Comparison Agios Pharmaceuticals (AGIO) P/E with competitors
Agios Pharmaceuticals (AGIO) P/E is -5.17.